For IPO Boutique's "scale of 1 to 5" BUY rating on Reata Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".
Reata Pharmaceuticals Quote & Chart - Click for current quote - RETA
About Reata Pharmaceuticals (adapted from Reata Pharmaceuticals prospectus): Reata is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways involved in the regulation of cellular metabolism and inflammation.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "RETA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
Used our Comprehensive Single Promo Advisory and want more?
